Table 1.
Reference | Liver function abnormality | Rate of abnormality in HPN patients (%) | Note |
---|---|---|---|
Luman12 | Abnormal LFTs | 48 | ↑Alkaline phosphatase commonest abnormality |
Salvino63 | Abnormal LFTs | 95 | |
Cavicchi10 | Chronic biochemical cholestasis* | 65 after 6 months | High lipid content in PN |
Lloyd13 | Chronic biochemical cholestasis* | 24 | Point prevalence |
Ito64 | Advanced liver disease† | 19 | |
Chan65 | Advanced liver disease† | 14 | |
Cavicchi10 | Complicated liver disease† | 26 at 2 years | High lipid content in PN |
50 at 6 years | |||
Salvino63 | Severe liver disease‡ | 4 |
Persistent elevation to >1.5 times the upper limit of the normal range for >6 months of two of three biochemical variables (alkaline phosphatase, γ-glutamyl transferase and conjugated bilirubin).
Fibrosis or cirrhosis.
Combination of total bilirubin >3 mg/dl, albumin <3.2 g/dl and prothrombin time >3 s prolonged.
HPN, home parenteral nutrition; LFTs, liver function tests; PN, parenteral nutrition.